RAD June 2021 Virtual Conference

If you have registered for the Conference and did not receive an email with a link to access the program, please check your spam/junk mail. If you do not see anything in your spam/junk folder, please email Donna Jimenez: djimenez@dnadigitalgroup.com

Technical Support is available to assist you with technical questions during the Conference. Please email: rad@cei-help.freshdesk.com

Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.

Our Virtual Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

Target Audience

This activity is intended for physicians, registered nurses and other healthcare providers engaged in the care of patients with Atopic Dermatitis.

Educational Objectives

After completing this activity, upon diagnosis and assessment of severity of AD, the participant should be better able to:

  • Use evidence-based treatment approaches for atopic dermatitis
  • Use improved understanding of pathophysiology, disease course and current, available treatment options in therapeutic decision making for atopic dermatitis and related comorbidities
  • Discuss the remaining unmet needs in the treatment of atopic dermatitis
  • Describe emerging therapies in the treatment of atopic dermatitis

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Foundation for Dermatology Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.0 contact hours.

Please note that you will not receive an email confirming registration until after the fee has been paid. If you have a discount code, please enter the code when registering. Once you do so and complete the required registration information, you will receive a confirmation email.